Skip to main content

Want a detailed portfolio tracker?

Entera Bio (ENTX) P/E (2021 - 2026)

Entera Bio (ENTX) P/E from Jun 30, 2021 to Jul 21, 2026. The TTM Entera Bio (ENTX) P/E is -7.28. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Entera Bio (ENTX)

YearP/EChange
2026-7.28-5.91%
2025-7.74-5.32%
2024-8.18+369.69%
2023-1.74+16.98%
2022-1.49-81.04%
2021-7.85N/A

Comparison Entera Bio (ENTX) P/E with competitors

Entera Bio (ENTX) P/E is -7.28.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.02%
NBYStablecoin Development Corp0.00-100.06%
ENLVEnlivex Ltd0.07-101.03%
FGENFibroGen Inc0.24-103.30%
CHRSCoherus Biosciences Inc0.85-111.65%
FBIOFortress Biotech Inc0.95-113.03%
ORMPOramed Pharmaceuticals Inc1.50-120.63%
AGENAgenus Inc3.01-141.31%
INVAInnoviva Inc3.15-143.30%
VXRTVaxart Inc3.55-148.73%
CRMDCorMedix Inc3.63-149.81%
CVACCureVac N.V.4.45-161.03%
GLPGGalapagos NV4.86-166.70%
SRPTSarepta Therapeutics Inc4.88-167.02%
ABEOAbeona Therapeutics Inc5.39-173.96%
ABUSArbutus Biopharma Corp5.60-176.81%
ZVRAZevra Therapeutics Inc5.89-180.82%
SPROSpero Therapeutics Inc6.23-185.50%
CGENCompugen Ltd6.31-186.67%
RIGLRigel Pharmaceuticals6.87-194.34%
SLXNSilexion Therapeutics Corp7.30-200.16%
OMEROmeros Corporation9.26-227.10%
AUPHAurinia Pharmaceuticals Inc9.58-231.58%
PLXProtalix BioTherapeutics Inc10.89-249.51%
ACADAcadia Pharmaceuticals Inc11.73-261.00%
TBPHTheravance Biopharma Inc12.26-268.33%
ADMAAdma Biologics Inc12.42-270.47%
HRMYHarmony Biosciences Holdings Inc13.82-289.72%
SABSSAB Biotherapeutics Inc14.14-294.06%
NAGENiagen Bioscience Inc14.82-303.42%
INCYIncyte Corp15.82-317.20%
REGNRegeneron Pharmaceuticals Inc15.86-317.67%
PBYIPuma Biotechnology Inc17.32-337.70%
CPRXCatalyst Pharmaceuticals Inc17.44-339.40%
EXELExelixis Inc17.54-340.75%
TGTXTG Therapeutics Inc18.97-360.36%
MDXGMimedx Group Inc20.55-382.14%
XOMAXOMA Royalty Corp22.87-414.02%
ARGXArgen X SE24.30-433.56%
CTMXCytomX Therapeutics Inc24.82-440.74%
XOMAOXOMA Royalty Corp25.34-447.93%
HALOHalozyme Therapeutics Inc25.62-451.76%
XOMAPXOMA Royalty Corp25.67-452.40%
VRTXVertex Pharmaceuticals Inc27.99-484.31%
RPRXRoyalty Pharma plc - Class A28.69-493.82%
SLNOSoleno Therapeutics Inc29.02-498.32%
ASNDAscendis Pharma A/S30.09-513.01%
LGNDLigand Pharmaceuticals Inc - Class B37.91-620.45%
APLSApellis Pharmaceuticals Inc39.02-635.68%
BMRNBiomarin Pharmaceutical Inc42.21-679.48%
KRYSKrystal Biotech Inc45.34-722.47%
ONCBeiGene Ltd69.54-1054.64%
PHARPharming Group N.V.75.03-1129.94%
TECHBio-Techne Corp101.96-1499.68%
VCELVericel Corp109.92-1608.99%
ALNYAlnylam Pharmaceuticals Inc117.96-1719.41%
GMABGenmab140.29-2025.90%
TLXTelix Pharmaceuticals Ltd162.15-2326.02%
CORTCorcept Therapeutics Inc212.86-3022.09%